Trial Profile
A Double-Blind, Randomized, Placebo-Controlled, 5-Period Crossover Study to Evaluate the Effects of a Single Dose of Losartan, a Single Dose of Isosorbide Mononitrate (ISMN), and Single Doses of Losartan + ISMN on Central Blood Pressure Measurements in Mildly Hypertensive Patients.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Isosorbide mononitrate
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Organon
- 28 Jul 2009 New trial record